Related by context. Frequent words. (Click for all words.) 67 Shareholder Letter 67 Key Milestones 65 Positive Cash Flow 61 FY# Guidance 60 Patient Enrollment 60 Option Grants 60 Stock Buyback Program 60 Epilepsy Drug 60 Merger Transaction 60 Milestone Payment 59 Revised Guidance 59 Vicor Technologies 59 Lifts FY# Outlook 58 Paivis Corp. 58 Compliance Requirements 57 Share Repurchases 57 Annual Meeting Date 57 Fibrocell Science Inc. 57 Sunesis Pharmaceuticals 57 Provides Shareholder 57 Operational Highlights 57 Mechel Announces 57 Clinical Trial Results 57 RONA inc 57 Quarterly Activities 57 Significantly Improved 57 Trueclaim Exploration Inc. 56 Inhaled Insulin 56 Organizational Changes 56 Prostate Cancer Patients 56 Shareholder Update 56 Regulatory Requirements 56 Gemini Explorations Inc. 56 Transcept Pharmaceuticals 56 Strategic Alternatives 56 YEAR ENDED 56 Fero Industries Inc. 56 Sino Agro Food 55 Cholesterol Drugs 55 Weight Loss Drug 55 Intellectual Property Portfolio 55 Genetic Tests 55 Bought Deal Financing 55 Shelf Registration 55 Upward Trend 55 RNAi Therapeutics 55 Share Buyback Program 55 Previously Announced 55 Summarizes 55 Third Quarter Dividend 55 Sustained Growth 55 Provides Guidance 55 Enable IPC Corporation 55 Private Placement Offering 55 Migao Corporation 55 ARCA biopharma 55 Resume Trading 55 Opns 55 BioDelivery Sciences 55 VIPR Industries Inc. 55 Review Initiated 54 Anemia Drugs 54 Substantial Issuer Bid 54 Achieving Success 54 Successful Completion 54 Significant Developments 54 http:/www.baxa.com 54 Keryx Biopharmaceuticals 54 Clinical Trials Update 54 Fast Track Status 54 Debt Conversion 54 Cautionary Factors 54 Significant Increase 54 Pluristem Therapeutics 54 CA BUSINESS 54 Announces Postponement 54 Infill Drilling 54 Approve Merger 54 Cholesterol Drug 54 Shareholder Approval 54 Sinobiomed 54 Appendix 4E 54 Common Share Dividend 54 By SEAN GALLAGHER 54 Racial Disparities 54 Cost Reductions 54 Final Tranche 54 Dividend Declared 54 Second Quarter Dividend 54 Share Repurchase Authorization 54 Record Second Quarter 54 SUBSEQUENT EVENTS 54 Drug Candidate 54 PositiveID Corporation 54 Succession Plan 53 Profitable Quarter 53 PrimeGen Energy 53 Renewable Energy Projects 53 Arthritis Drug 53 Forecast Quick Facts 53 Oroco Resource Corp.